
Course Description
This course explores the most challenging management problems that clinicians face when treating patients with pulmonary embolism (PE) and the complications of this important and potentially fatal condition. Distinguished faculty from multiple specialties (pulmonary/critical care, cardiology, interventional radiology, emergency medicine, anesthesia/critical care, thoracic surgery, and hematology/oncology) will present current information in the areas of pulmonary embolism pathophysiology, epidemiology, risk factors, diagnosis, risk stratification, medical and interventional management, novel treatments, outcomes, and complications. The conference also emphasizes interaction between participants and faculty and allows ample time for case presentations and group panel discussions with a specific emphasis on the practicalities of forming a multidisciplinary Pulmonary Embolism Response Team (PERT). The combination of didactics with a virtual PERT meeting ensures an outstanding interactive educational experience for attendees.
Target Audience
This course is targeted toward physicians active in the diagnosis and management of PE and Venous ThromboEmbolism (VTE), including pulmonology, critical care, hematology, cardiology, emergency medicine, interventional radiology, cardiac surgery, internal medicine, radiology and anesthesiology. Fellows, residents and allied health professionals such as nurse practitioners will also gain invaluable knowledge.
Registration Information
Enrollment
To enroll click here.
By Mail
Send the completed enrollment form to:
David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
Pulmonary Embolism Care 2018
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By Fax
Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.
By Phone
Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620
Course Fees
- $150 Physicians
- $50 Nurses, Allied Health Professionals
- $50 Fellows, Residents
Refunds
Cancellations must be received in writing by Friday, October 19, 2018 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.
Faculty
Course Directors
John Moriarty, MD, FSIR
Co-Director, UCLA PERT
Associate Professor, Radiology and Medicine
Interventional Radiology
David Geffen School of Medicine at UCLA
Marcella Calfon Press, MD, PhD, FACC
Co-Director, UCLA PERT
Assistant Clinical Professor
Division of Cardiology, Department of Medicine
David Geffen School of Medicine at UCLA
Tisha Wang, MD
Co-Director, UCLA PERT
Associate Professor of Clinical Medicine
Clinical Division Chief
Fellowship Program Director
Division of Pulmonary and Critical Care Medicine, Department of Medicine
David Geffen School of Medicine at UCLA
Course Faculty
Olcay Aksoy, MD, FACC
Assistant Professor of Medicine
Division of Cardiology, Department of Medicine
David Geffen School of Medicine at UCLA
Igor Barjaktarevic, MD, PhD
Assistant Professor
Medical Director, COPD Program
Director of Critical Care Ultrasound
Division of Pulmonary and Critical Care, Department of Medicine
David Geffen School of Medicine at UCLA
Richard Channick, MD
Professor of Medicine, Pulmonary and Critical Care Division
Director, Acute and Chronic Thromboembolic Disease Program
David Geffen School of Medicine at UCLA
Oren Friedman, MD
Associate Director, Cardiac Surgery ICU
Department of Surgery
Cedars-Sinai Medical Center
Los Angeles, California
Scott Genshaft, MD
Assistant Professor
Thoracic and Interventional Radiology
David Geffen School of Medicine at UCLA
Vadim Gudzenko, MD
Associate Clinical Professor
Director, ACCM Fellowship
Medical Director, Adult ECMO Service
Division of Critical Care, Department of Anesthesiology and Perioperative Care
David Geffen School of Medicine at UCLA
Kanwar Kahlon, MD
Assistant Professor
Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Stephen Kee, MD, MMM, FSIR
Professor of Radiology
Division Chief, Interventional Radiology
David Geffen School of Medicine at UCLA
Lynne McCullough, MD, FACEP
Professor
Department of Emergency Medicine
Medical Director, Ronald Reagan UCLA Emergency Department
David Geffen School of Medicine at UCLA
Adam Plotnik, MD
Assistant Professor
Co-Director of UCLA IVC Filter Clinic
Division of Interventional Radiology, Department of Radiological Sciences
David Geffen School of Medicine at UCLA
Nida Qadir, MD
Assistant Clinical Professor of Medicine
Division of Pulmonary and Critical Care Medicine, Department of Medicine
David Geffen School of Medicine at UCLA
Danny Ramzy, MD
Surgical Director, Lung Transplant Program
Director, Robotic & Minimally Invasive Cardiac Surgery
Cedars-Sinai Medical Center
Los Angeles, California
Rajan Saggar, MD
Associate Professor of Medicine
Director, Medical Intensive Care Unit
Lung and Heart-Lung Transplant and Pulmonary Hypertension Programs
David Geffen School of Medicine at UCLA
Jonathan Soverow, MD, MPH
Health Sciences Assistant Clinical Professor of Medicine
Associate Director, Cardiac Catheterization Laboratory
Olive View-UCLA Medical Center
David Geffen School of Medicine at UCLA
Victor Tapson, MD
Director, Venous Thromboembolism and Pulmonary Vascular Disease Research
Program Director, Clinical Research, Women’s Guild Lung Institute
Associate Director, Pulmonary and Critical Care Medicine
Cedars-Sinai Medical Center
Los Angeles, California
Aaron S. Weinberg, MD, MPhil
Pulmonary & Critical Care Faculty Physician
Associate Director, VTE Disease and Research
Division of Pulmonary & Critical Care
Department of Internal Medicine
Co-Communications Chair, National PERT Consortium
Cedars-Sinai Medical Center
Los Angeles, California
Deborah Wong, MD, PhD
Assistant Clinical Professor
Division of Hematology/Oncology, Department of Medicine
David Geffen School of Medicine at UCLA
Eric H. Yang, MD, FACC, FASE
Assistant Clinical Professor of Medicine
Director, UCLA Cardio-Oncology Program
Associate Program Director, Cardiovascular Diseases Fellowship
Division of Cardiology, Department of Medicine
David Geffen School of Medicine at UCLA
Program Agenda
Saturday, November 17, 2018 |
|
7:00 | Registration and Breakfast |
Acute PE: Diagnosis and Triage Moderator: John Moriarty, MD, FSIR |
|
8:00 |
Welcome and Introductory Remarks John Moriarty, MD, FSIR |
8:05 |
Acute PE: Scope of the Problem Tisha Wang, MD |
8:20 |
Risk Stratification in Acute PE: Half the Battle Marcella Calfon Press, MD, PhD, FACC |
8:35 |
Imaging in PE: Who, How, and What’s Next Scott Genshaft, MD |
8:50 | Panel and Q&A |
Low Risk PE Moderator: Tisha Wang, MD |
|
9:00 |
Anticoagulation for PE in the Age of DOACS Kanwar Kahlon, MD |
9:15 |
Rapid Discharge from ER: When Is It Safe to Send Home Lynne McCullough, MD, FACEP |
9:30 |
Cancer and Thrombophilia Work Up: Who and How to Investigate Further Deborah Wong, MD, PhD |
9:45 | Panel and Q&A |
10:00 | Break |
Submassive PE Moderator: Marcella Calfon Press, MD, PhD, FACC |
|
10:30 |
ECHO of the In-Danger RV Eric H. Yang, MD, FACC, FASE |
10:45 |
Systemic Lysis for Submassive PE Nida Qadir, MD |
11:00 |
Catheter Directed Therapy for Submassive PE: Not Just Lysis Stephen Kee, MD, MMM, FSIR |
11:15 |
Panel and Q&A Moderator: John Moriarty, MD, FSIR |
11:25 |
Keynote Lecture PE Response Teams: The Way of the Future? Richard Channick, MD |
12:00 | Lunch |
Submassive and Massive PE Moderator: Tisha Wang, MD |
|
1:00 |
IVC Filters: When, and When Not, to Use in Acute PE Adam Plotnik, MD |
1:15 |
Surgical Management of Acute PE Danny Ramzy, MD |
1:30 |
Clot in Motion: PE Response Team in Motion John Moriarty, MD, FSIR |
1:45 |
Critical Care of the Massive PE Patient Igor Barjaktarevic, MD, PhD |
2:00 |
Systemic Lysis: How Much to Give and How to Give It Oren Friedman, MD |
2:15 |
ECMO in PE: Life Saving or just Preserving? Vadim Gudzenko, MD |
2:30 | Panel and Q&A |
2:45 | Break |
Special Topics in PE Moderator: Marcella Calfon Press, MD, PhD, FACC |
|
3:15 |
CTEPH: Who and How to Follow after Acute PE Victor Tapson, MD |
3:30 |
CTEPH: Treatment Options in 2018 Rajan Saggar, MD |
3:45 |
PE in Special Populations: Lung Transplant, Morbid Obesity and Pediatrics Aaron S. Weinberg, MD, MPhil |
4:00 |
PE in Special Populations: Pregnancy, High Bleeding Risk and the Patient with Cancer Olcay Aksoy, MD, FACC |
4:15 | Panel and Q&A |
4:30 | Break |
Virtual PERT Moderator: John Moriarty, MD, FSIR |
|
4:45 |
Virtual PE Response Team: Expert Faculty Debate Their Best and Worst Cases Panelists: Drs. Calfon Press, Channick, Friedman, Kee, Soverow, Tapson, Wang |
6:00 | Adjourn |
Objectives
At the completion of this program, participants should be better able to:
- Understand key aspects of the latest advances in the pathophysiology, risk factors, and diagnosis of PE
- Utilize echocardiogram and other imaging modalities in the evaluation of patients with suspected and confirmed PE
- Risk stratify patients into low-risk, submassive, and massive PE categories to better identify populations that are high risk for morbidity and mortality from their PE
- Manage patients with both low-risk and high-risk PE with a variety of treatment options, including anticoagulation, medical and interventional lysis strategies, and surgical therapies
- Recognize the potential short-term and long-term complications from PE and how to prevent and treat them
- Highlight unique patient populations with PE and their specific treatment challenges
- Promote and enhance coordinated multidisciplinary care of PE patients with a specific focus on the use of PERT teams
Accreditation
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Disclosures
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
Miscellaneous
Program Location
UCLA Meyer and Renee Luskin Conference Center
425 Westwood Plaza
Los Angeles, CA 90095
855-522-8252
Directions and Parking
From the 405 freeway, exit Wilshire Blvd., east toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay per license plate at the kiosk and display the parking permit on your dash. All day self-parking is $12.00. Walk down one level and across pedestrian walkway toward Luskin Conference Center. Enter through Luskin Conference Center doors on right side.